Abstract:
The present invention discloses a novel use of a lanostane having the following formula (I) in treating a disease induced from immune disorder: wherein R1 is either H or CH3; R2 is OCOCH3, ═O or OH; R3 is H or OH; R4 is —C(═CH2)—C(CH3)2Ra, in which Ra is H or OH, or —CH═C(CH3)—Rb, in which Rb is CH3 or CH2OH; R5 is H or OH; and R6 is CH3 or CH2OH.